Rebound Phenomenon after Intravitreal Injection of Triamcinolone Acetonide for Macular Edema

Conclusion: Our study shows that 9.7% of the eyes with ME secondary to DR and RVO developed a rebound phenomenon following IVTA injection, limiting its therapeutic effect. We found an increased number of prior intravitreal pharmacotherapy to be a risk factor for a rebound phenomenon.Ophthalmologica
Source: Ophthalmologica - Category: Opthalmology Source Type: research